75000 - Document - Cover Page
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Interim Consolidated Statements of Financial Position (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Interim Consolidated Statements of Comprehensive Loss (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Interim Consolidated Statements of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Disclosure - Nature of Operations
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Disclosure - Basis of Presentation and Material Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
75070 - Disclosure - Adoption of New Accounting Standards
link:presentationLink
link:calculationLink
link:definitionLink
75080 - Disclosure - Critical Accounting Estimates And Judgements
link:presentationLink
link:calculationLink
link:definitionLink
75090 - Disclosure - Property and Equipment
link:presentationLink
link:calculationLink
link:definitionLink
75100 - Disclosure - Intangible Assets
link:presentationLink
link:calculationLink
link:definitionLink
75110 - Disclosure - Convertible Debentures
link:presentationLink
link:calculationLink
link:definitionLink
75120 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
75130 - Disclosure - Share Capital
link:presentationLink
link:calculationLink
link:definitionLink
75140 - Disclosure - Employee Remuneration
link:presentationLink
link:calculationLink
link:definitionLink
75150 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
75160 - Disclosure - Commitments
link:presentationLink
link:calculationLink
link:definitionLink
75170 - Disclosure - Grant and Subsidy Income
link:presentationLink
link:calculationLink
link:definitionLink
75180 - Disclosure - Financial Instruments
link:presentationLink
link:calculationLink
link:definitionLink
75190 - Disclosure - Inventories
link:presentationLink
link:calculationLink
link:definitionLink
75200 - Disclosure - Segmented Information and Economic Dependence
link:presentationLink
link:calculationLink
link:definitionLink
75210 - Disclosure - Supplemental Cash Flow Information
link:presentationLink
link:calculationLink
link:definitionLink
75220 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
75230 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
75240 - Disclosure - Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
75250 - Disclosure - Basis of Presentation and Material Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75260 - Disclosure - Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75270 - Disclosure - Property and Equipment (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75280 - Disclosure - Intangibles assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75290 - Disclosure - Goodwill (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75300 - Disclosure - Convertible Debentures (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75310 - Disclosure - Leases (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75320 - Disclosure - Share Capital (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75330 - Disclosure - Employee Remuneration (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75340 - Disclosure - Related Party Transactions (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75350 - Disclosure - Financial Instruments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75360 - Disclosure - Inventories (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75370 - Disclosure - Segmented Information and Economic Dependence (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75380 - Disclosure - Supplemental Cash Flow Information (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75390 - Disclosure - Income Taxes (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
75400 - Disclosure - Nature of Operations - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75410 - Disclosure - Basis of Presentation and Material Accounting Policies - Summary of Subsidiaries Using Their Historical Names which are Wholly Owned and Subject to Control (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75420 - Disclosure - Basis of Presentation and Material Accounting Policies - Summary of Divestiture Classified as Held for Sale (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75430 - Disclosure - Basis of Presentation and Material Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75440 - Disclosure - Basis of Presentation and Material Accounting Policies - Summary of Discontinued Operations (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75450 - Disclosure - Investment - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75460 - Disclosure - Property and Equipment - Summary of Changes in the Value of Property and Equipment (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75470 - Disclosure - Intangibles Assets - Summary of Changes in the Value of the Intangible Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75480 - Disclosure - Convertible Debentures - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75490 - Disclosure - Leases - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75500 - Disclosure - Leases - Schedule of Future Minimum Lease Payments Related to Equipment under Finance Lease and Office Lease Obligation (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75510 - Disclosure - Leases - Schedule of Disclosure in Tabular Form of Nature of Companies Leases (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
75520 - Disclosure - Leases - Schedule of Changes in the Value of the Right-of-Use Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75530 - Disclosure - Leases - Schedule of Disclosure in Tabular Form Of Expenses Relating to Payments not included (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
75540 - Disclosure - Share Capital - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75550 - Disclosure - Share Capital - Summary of Stock Option Awards (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75560 - Disclosure - Share Capital - Summary of Stock Option Awards (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75570 - Disclosure - Share Capital - Summary of Changes in Stock Option (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75580 - Disclosure - Share Capital - Summary of Options Outstanding (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75590 - Disclosure - Share Capital - Summary of Options Outstanding (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75600 - Disclosure - Share Capital - Summary of Changes in Warrants and Finder's Warrants (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75610 - Disclosure - Share Capital - Details of Warrants and Finder's Warrants Outstanding (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75620 - Disclosure - Share Capital - Details of Warrants and Finder's Warrants Outstanding (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75630 - Disclosure - Share Capital - Summarizes Activity Related to RSUs (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75640 - Disclosure - Employee Remuneration - Summary of Expenses Recognized for Employee Benefits (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75650 - Disclosure - Related Party Transactions - Schedule of Compensation For Key Management (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75660 - Disclosure - Related Party Transactions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75670 - Disclosure - Commitments - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75680 - Disclosure - Grant and Subsidy Income - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75690 - Disclosure - Financial Instruments - Schedule of Details of Amounts Receivable and Allowances for Credit Losses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75700 - Schedule - Inventories - Summary of Detailed Information About Inventories (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
75710 - Disclosure - Inventories - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75720 - Disclosure - Segmented Information and Economic Dependence - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75730 - Disclosure - Segmented Information and Economic Dependence - Summary of Geographical Segments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75740 - Disclosure - Segmented Information and Economic Dependence - Summary of Revenues Allocated According to Revenue Types (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75750 - Disclosure - Supplemental Cash Flow Information - Summary of Non-cash Investing and Financing Transactions (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75760 - Disclosure - Supplemental Cash Flow Information - Summary of Changes in Liabilities Arose From Financing Activities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
75770 - Disclosure - Subsequent Events - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
999009 - Disclosure - Anchoring
link:presentationLink
link:calculationLink
link:definitionLink
Cash outflow for leases
Cash outflow for leases
Summary of Changes in Finder's Warrants
Disclosure Of Changes In Finders Warrants Explanatory
Disclosure of changes in Finders Warrants.
Current prepaid expenses
Prepaid expenses
Accounts payable and accrued liabilities
Current Accounts Payable And Accrued Liabilities
Current accounts payable and accrued liabilities.
Top of Range
Top of range [member]
Non-cash changes, Foreign exchange movements and change in estimates
Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities
Weighted average life remaining (years)
Weighted Average Life Remaining Class Of Warrants
Weighted average life remaining, class of warrants.
Option Eight [Member]
Option eight.
Option 8
Option Expiry Date May 8, 2033
Increase (decrease) through share-based payment transactions, equity
Share-based expense
Classes of property, plant and equipment [axis]
Classes of property, plant and equipment [axis]
Revenue Expense From Government Grants
Revenue (expense) from government grants.
Grant income
Principal amount of convertible debentures that holders cannot convert without prior written consent during any consecutive thirty day period
Principal Amount of Convertible Debentures that Holders Cannot Convert without Prior Written Consent During any Consecutive Thirty Day Period
Principal Amount of Convertible Debentures that Holders Cannot Convert without Prior Written Consent During any Consecutive Thirty Day Period.
Payments of lease liabilities
Repayment of leases
Payments of lease liabilities, classified as financing activities
Increase decrease through at-the-market value of shares.
Increase Decrease Through At-the-market Value Of Shares
Shares issued pursuant to ATM, net of issuance costs
Non-current portion
Non-current lease liabilities
Expected life
Option life, share options granted
Document Fiscal Period Focus
Non-cash changes, Debt forgiven/ Settlement/ Disposal
Increase Decrease Through Debt Forgiven Or Settlement Or Disposal Liabilities Arising From Financing Activities
Increase decrease through debt forgiven or settlement or disposal liabilities arising from financing activities.
Disclosure of detailed information about intangible assets [abstract]
Additions other than through business combinations, property, plant and equipment including right-of-use assets
Addition of equipment by lease
Remaining life (year)
Warrants Outstanding Remaining Life
Warrants outstanding remaining life.
Goodwill
Description of accounting policy for goodwill [text block]
Net cash flows from (used in) financing activities
Cash flows from (used in) financing activities
Net cash used in financing activities
Shares issued pursuant to deferred payment for acquisition, Number of Shares
Shares issued pursuant to deferred acquisition, shares
Increase Decrease Through Acquisition Of Subsidiary Number Of Shares
Increase (decrease) through acquisition of subsidiary, number of shares.
Severance (included in salaries)
Key management personnel compensation, post-employment benefits
Disclosure In Tabular Form Of Nature Of Companies Leases [Line Items]
Disclosure in tabular form of nature of companies leases.
Expiry Date
Options Outstanding Expiry Date
Options outstanding expiry date.
ImmunoPrecise Netherlands B.V.
Immuno Precise Netherlands B V [Member]
ImmunoPrecise Netherlands B.V.
Shares issued pursuant to issuance of common shares
Carrying value of equity
Issue of equity
Commitments [Line Items]
Commitments.
Foreign exchange
Effect of exchange rate changes on cash and cash equivalents
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items]
Disclosure of reconciliation of liabilities arising from financing activities [line items]
No. of leases with variable payments linked to an index
Number Of Leases With Options To Purchase
Number of leases with options to purchase.
Summary of Differences and Related Tax Effects
Disclosure Of Related Tax Effects Explanatory
The disclosure of related tax effects.
Total cash
Cash
Cash
February 20, 2024
Twenty February Twenty Twenty Four Member
Twenty February twenty twenty four.
Number of common shares sold.
Number of common shares sold/issued
Convertible debentures interest rate
Convertible Debentures Interest Rate
Convertible debentures interest rate.
Basic earnings (loss) per share from discontinued operations
INCOME PER SHARE FROM DISCONTINUED OPERATIONS- BASIC
Certifications
Certifications
Certifications [Member]
Certifications.
Not Later Than One Year
Not later than one year [member]
2027
MindWalk Biologics
MindWalk Biologics [Member]
MindWalk Biologics.
Business combinations
Description of accounting policy for business combinations and goodwill [text block]
BioStrand B.V. d/b/a MindWalk [Member]
Biostrand B.V. d/b/a mindwalk.
BioStrand B.V. d/b/a MindWalk
Minimum contingent earnout payment
Minimum Contingent Earnout Payment
Minimum contingent earnout payment.
November 13, 2023
Thirteen November Twenty Twenty Three Member
Thirteen November twenty twenty three.
Segments [domain]
Shares issued pursuant to warrant exercise
Shares issued pursuant to warrant exercise
Increase (decrease) through exercise of warrants, equity
Summary of Temporary Differences to Deferred Income Tax Assets and Liabilities
Disclosure of deferred taxes [text block]
BioKey BV [Member]
Biokey BV.
BioKey BV
Cost of sales
Cost of sales
COST OF SALES
Total cash and cash equivalents
Cash
Cash and cash equivalents
Cash - beginning of the period
Cash - end of the period
IPA Europe
Immuno Precise Antibodies Europe B V [Member]
ImmunoPrecise Antibodies (Europe) B.V.
ASSETS
Assets [abstract]
LEASES
Disclosure of leases [text block]
Option Ten [Member]
Option ten.
Option Expiry Date August 8, 2033
Disclosure of transactions between related parties [abstract]
Comprehensive income
Comprehensive loss for the period
COMPREHENSIVE LOSS FOR THE PERIOD
Comprehensive loss for the period
Lease Obligation Monthly Repayments Amount
Lease obligation monthly repayment amount.
Interest and accretion
Grant awarded
Government grants
Impairment of long-lived assets
Description of accounting policy for impairment of assets [text block]
Carrying amount [member]
Carrying amount [member]
Summary of Changes in Warrants
Disclosure Of Changes In Warrants Explanatory
Disclosure of changes in warrants.
Weighted Average Exercise Price Of Share Options Vested and Outstanding
Weighted average exercise price of share options vested and outstanding.
Weighted average exercise price, Vested and outstanding
Summary of Changes in Value of New Debentures
Disclosure Of Changes In Value Of New Debentures Table [Text Block]
Disclosure of changes in value of new debentures.
WIP - Leasehold Improvements
Work In Progress Leasehold Imrpvements [Member]
Work In Progress Leasehold Imrpvements.
LOSS PER SHARE FROM CONTINUING OPERATIONS- DILUTED
Diluted earnings (loss) per share from continuing operations
Total present value of minimum lease payments
Lease liabilities
Country of Incorporation
Country of incorporation of subsidiary
Cryo Storage Revenue
Cryo Storage [Member]
Cryo storage.
Total intangible assets other than goodwill
Intangible assets
Beginning balance
Ending balance
Intangible assets other than goodwill
Shares issued pursuant to option exercise
Shares issued pursuant to option exercise
Increase (decrease) through exercise of options, equity
Schedule of Details of Amounts Receivable and Allowances for Credit Losses
Disclosure of allowance for credit losses [text block]
Disclosure of non-adjusting events after reporting period [abstract]
Subsidiaries [domain]
January 19, 2024
Nineteen January Twenty Twenty Four [Member]
Nineteen January Twenty Twenty Four.
BioKey B.V [Member]
BioKey B.V.
BioKey BV
Option One [Member]
Option one.
Option Expiry Date January 7, 2027
Disclosure of non-adjusting events after reporting period [line items]
Employee benefits
Other short-term employee benefits
Profit (loss) before tax
Loss before income taxes and discontinued operations
Income (loss) before income taxes
Equity Interest percentage
Proportion of ownership interest in subsidiary
Disclosure Of Geographical Areas [Line Items]
Disclosure of geographical areas [line items]
Total revenue
REVENUE
Revenues
Diluted earnings (loss) per share from discontinued operations
INCOME PER SHARE FROM DISCONTINUED OPERATIONS- DILUTED
Net proceeds received from sale of business
Net proceeds received from sale of business.
Net proceeds received
Unpaid commitment related to earnout
Unpaid commitment related to earnout
Unpaid commitment related to earnout.
Disclosure Of Maturity Analysis Of Finance And Office Lease Payments [Table]
Disclosure Of Maturity Analysis Of Finance And Office Lease Payments [Table]
Disclosure of maturity analysis of finance and office lease payments.
Net cash flows from (used in) operating activities
Net cash used in operating activities
Cash flows from (used in) operating activities
Liabilities
Liabilities
Total liabilities
Liabilities at beginning of period
Liabilities at end of period
Liabilities
Total liabilities
Disposal groups classified as held for sale [member]
Divestiture Classified as Held for Sale
Liabilities arising from financing activities [domain]
Classes of current inventories [abstract]
Summary of Options Outstanding
Disclosure of range of exercise prices of outstanding share options [text block]
Additions
Additions other than through business combinations, property, plant and equipment
Discontinued operations [member]
Discontinued Operations
Exercised, Number of warrants
Number Of Warrants Exercised
Number of warrants exercised.
Amendment Flag
SHARE CAPITAL
Disclosure of share capital, reserves and other equity interest [text block]
Disclosure Of Property Plant And Equipment [Line Items]
Disclosure of detailed information about property, plant and equipment [line items]
Borrowings by name [domain]
Entity Address, Postal Zip Code
Categories of related parties [domain]
May 8, 2023
Eight May Twenty Twenty Three Member
Eight May twenty twenty three.
Discontinued operations in property, plant and equipment
Discontinued operations in property, plant and equipment.
Discontinued operations
Weighted average life remaining (years), Unvested
Weighted Average Remaining Life Of Unvested Share Options
Weighted average remaining life of unvested share options.
Issued, Number of warrants
Number Of Warrants Issued
Number of warrants issued.
Restricted cash
Noncurrent Restricted Cash
Noncurrent restricted cash.
Fair value
Weighted average fair value at measurement date, share options granted
Entity Address, Address Line One
Summary of Amortization of Intangible Assets with Finite Lives
Disclosure Of Amortization Of Intangible Assets With Finite Lives [Text Block]
Disclosure of amortization of intangible assets with finite lives.
Foreign exchange
Foreign Exchange
Foreign exchange.
Stock Options Grant Date [Axis]
Stock options grant date.
Consideration received on sale of business
Consideration received on sale of business.
Total enterprise value
Foreign exchange
Payments Proceeds To Right of Use Assets Foreign Exchange Effect
Payments proceeds to right of use assets foreign exchange effect.
Increase decrease through at-the-market number of shares.
Increase Decrease Through At-The-Market Number Of Shares
Shares issued pursuant to ATM, net of issuance costs, shares
More than 5 years
Later than five years [member]
INCOME TAXES
Disclosure of income tax [text block]
Document Type
Aggregate principal amount of convertible debentures agreed to sell and issue
Aggregate Principal Amount of Convertible Debentures Agreed to Sell and Issue
Aggregate principal amount of convertible debentures agreed to sell and issue.
Percentage of revenue
Percentage of entity's revenue
Net cash flows from (used in) investing activities
Net cash used in investing activities
Cash flows from (used in) investing activities
Entity Central Index Key
Customer list
Customer List
Customer List [Member]
Customer list.
Bottom of Range
Bottom of range [member]
Disclosure Of Maturity Analysis Of Finance And Office Lease Payments [Line Items]
Disclosure Of Maturity Analysis Of Finance And Office Lease Payments [Line Items]
Disclosure of maturity analysis of finance and office lease payments.
Continuing and discontinued operations [axis]
Commitments [Abstract]
Commitments.
Geographical areas [axis]
Geographical areas [axis]
Other
All Other Countries [Member]
All other countries.
Disclosure of employee benefits expenses [abstract]
Disclosure of employee benefits expenses.
Amounts receivable, gross
Amounts Receivable Gross
Amounts receivable gross.
Related party transaction, due from (to) related party
Key management personnel compensation
Adjustments For Depreciation And Amortisation Expense From Discontinued Operations
Adjustments for depreciation and amortisation expense from discontinued operations.
Amortization and depreciation
Accumulated Deficit
Retained earnings [member]
Summary of Non-cash Investing and Financing Transactions
Disclosure Of Non Cash Investing And Financing Transactions Explanatory
Disclosure of non-cash investing and financing transactions.
Disposals
Disposals From Right Of Use Assets
Disposals from right of use assets.
Disclosure Of Geographical Areas [Table]
Disclosure of geographical areas [table]
Disclosure of subsidiaries [abstract]
June 11, 2023
Eleven June Twenty Twenty Three Member
Eleven June twenty twenty three.
Related party transactions [abstract]
Current Fiscal Year End Date
Inventories [Abstract]
Inventories
Ranges of exercise prices for outstanding share options [axis]
Ranges of exercise prices for outstanding share options [axis]
Assets held for sale
Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners
Total current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners
Less: imputed interest
Imputed Interest On Lease Liabilities
Imputed interest on lease liabilities.
Corporate
Corporate Segments [Member]
Corporate segments.
Disclosure of subsidiaries [text block]
Summary of Subsidiaries Using Their Historical Names which are Wholly Owned and Subject to Control
Prepaid expenses
Adjustments for decrease (increase) in prepaid expenses
Deferred Acquisition Payment Investing Activities
Deferred acquisition payment investing activities.
Deferred acquisition payments
Idea Family B.V [Member]
Idea Family B.V.
Idea Family BV
Cash included in asset held for sale
Cash included in asset held for sale
Cash included in asset held for sale
Intangible assets material to entity [domain]
EXPENSES
Expenses by nature [abstract]
Entity Address, State or Province
Share issuance costs
Description Of Accounting Policy For Share Issuance Costs Explanatory [Text Block]
Description of accounting policy for share issuance costs explanatory.
Immuno Precise Antibodies (Canada) Ltd. d/ba/ MindWalk Biologics [Member]
Immuno precise antibodies (canada) Ltd. d/ba/ mindwalk biologics.
ImmunoPrecise Antibodies (Canada) Ltd. d/ba/ MindWalk Biologics
Investments accounted for using equity method [abstract]
Shares issued pursuant to conversion of convertible debentures, shares
Issue Of Convertible Instruments Number Of Shares
Issue of convertible instruments number of shares.
Cash flows from (used in) investing activities, discontinued operations
Net cash flows from (used in) investing activities, discontinued operations
Net cash used in investing activities
Research and development
Description of accounting policy for research and development expense [text block]
Current liabilities
Current liabilities
Current liabilities
Write-downs (reversals of write-downs) of inventories [abstract]
Accumulated Amortization
Accumulated Amortization [Member]
Accumulated amortization.
Automobile
Automobile [Member]
Automobile.
Non-adjusting events after reporting period [axis]
Schedule of reconciliation of changes in goodwill
Disclosure of reconciliation of changes in goodwill [text block]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
Exchange difference on translating foreign operations
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
Accrued liabilities related parties current
Accrued Liabilities Related Parties Current
Accrued liabilities related parties current.
Amounts receivable, net
Current Amounts Receivable
Current amounts receivable.
Unrealized foreign exchange gain (loss)
Unrealized foreign exchange gain (loss).
Unrealized foreign exchange loss
Accounts payable due to related parties
Payables to related parties
Payroll taxes
Payroll taxes
Payroll taxes.
Premium percentage on convertible debentures issued
Premium Percentage on Convertible Debentures Issued
Premium percentage on convertible debentures issued.
Lab Equipment
Lab Equipment [Member]
Lab equipment.
Variable lease payments
Expense relating to variable lease payments not included in measurement of lease liabilities
Summary of Classification and Measurement of Financial Assets and Liabilities
Disclosure of detailed information about financial instruments [text block]
On and after November 1, 2024
On and After November One, Two Thousand Twenty Four [Member]
On and after November 1, 2024 member.
Exercise price
Exercise price of outstanding share options
Government assistance
Description Of Accounting Policy For Government Assistance [Text Block]
Description of accounting policy for government assistance.
Accumulated Other Comprehensive (Loss) Income
Accumulated other comprehensive income [member]
Weighted average exercise price, Forfeited
Weighted average exercise price of share options forfeited in share-based payment arrangement
Belgium
BELGIUM
Share-based payments
Description of accounting policy for share-based payment transactions [text block]
At The Market Equity Offering Facility
At The Market Equity Offering Facility [Member]
At the market equity offering facility.
Option Twelve [Member]
Option twelve.
Option Expiry Date February 19, 2034
Statistical Measurement
Range [axis]
Disclosure of operating segments [abstract]
Commitments [Table]
Commitments.
Investing activities:
Cash flows from (used in) investing activities [abstract]
Segments [axis]
Segments [axis]
Total minimum lease payments
Future Minimum Finance And Office Lease Payments
Future minimum finance and office lease payments.
Weighted average exercise price, Exercisable
Weighted average exercise price of share options exercisable in share-based payment arrangement
Percentage of purchase price to aggregate principal amount
Percentage of Purchase Price to Aggregate Principal Amount
Percentage of purchase price to aggregate principal amount.
Disclosure of terms and conditions of share-based payment arrangement [table]
Contributed Surplus
Additional paid-in capital [member]
BioStrand B.V.
BioStrand B.V. [Member]
Biostrand b.v.
Schedule of Nature of Company's Leases Type of Right-of-Use Asset
Summary of disclosure in tabular form of nature of companies leases
Disclosure In Tabular Form Of Nature Of Companies Leases
Disclosure in tabular form of nature of companies leases.
Classes of intangible assets other than goodwill [domain]
Internally generated development costs
Internally Generated Development Costs
Internally Generated Development Costs [Member]
Internally generated development costs.
Reclassified assets held for sale right of use assets
Reclassified assets held for sale right of use assets.
Reclassified assets held for sale
PROPERTY AND EQUIPMENT
Disclosure of property, plant and equipment [text block]
Summary of Revenue Recognized Over Time Versus at Point in Time
Disclosure of disaggregation of revenue from contracts with customers [text block]
Inventory write-offs
Inventory write-down
Conversion of convertible debt to equity terms
Description of conversion of debt to equity
Description of conversion of debt to equity
Exercisable price/option
Exercise price, share options granted
Summary of Changes in the Value of Property and Equipment
Disclosure of detailed information about property, plant and equipment [text block]
Products and services [axis]
Products and services [axis]
Project Revenue
Project Revenue [Member]
Project revenue.
Summary of Geographical Segments
Disclosure of geographical areas [text block]
Disclosure of reconciliation of liabilities arising from financing activities [abstract]
Wages, salaries
Salaries and benefits
Wages and salaries
Details of Finder's Warrants Outstanding
Disclosure Of Details Of Finders Warrants Outstanding Explanatory
Disclosure of details of Finder's warrants outstanding.
Australia
Australia [Member]
AUSTRALIA
Total liabilities and shareholders' equity
Equity and liabilities
Total liabilities and equity
Additions
Additions to right-of-use assets
Range One
Range One [Member]
Range one.
Types of antidilutive instruments [domain]
Revenue recognition
Description of accounting policy for recognition of revenue [text block]
Disclosure of analysis of single amount of discontinued operations [table]
No. of leases with termination options
Number Of Leases With Termination Options
Number of leases with termination options.
Liabilities included in disposal groups classified as held for sale
Liabilities held for sale
Stock Options Grant Date [Member]
Stock options grant date.
Adjustments for share-based payments
Share-based expense
Disclosure of quantitative information about right-of-use assets [abstract]
Monthly installments payments on convertible debentures principal amount
Monthly Installments Payments on Convertible Debentures Principal Amount
Monthly installments payments on convertible debentures principal amount.
Profit (loss) from discontinued operations
NET INCOME FROM DISCONTINUED OPERATIONS
NET INCOME FROM DISCONTINUED OPERATIONS
Disclosure In Tabular Form Of Nature Of Companies Leases [Table]
Disclosure in tabular form of nature of companies leases.
Option Thirteen [Member]
Option thirteen.
Option 13
Option Expiry Date August 2, 2034
Increase (decrease) through obtaining or losing control of subsidiaries or other businesses, liabilities arising from financing activities
Non-cash changes, Addition
Sales and income taxes payable and receivable
Adjustments For Increase Decrease In Taxes Payable And Receivable
Adjustments for increase (decrease) in taxes payable and receivable.
Earnings (loss) per share
Description of accounting policy for earnings per share [text block]
SUPPLEMENTAL CASH FLOW INFORMATION
Disclosure of cash flow statement [text block]
EMPLOYEE REMUNERATION
Disclosure of employee benefits [text block]
Capital requirements [axis]
Disclosure of initial application of standards or interpretations [abstract]
Less: Current portion
Current lease liabilities
Leases
Description of accounting policy for leases [text block]
Convertible Debentures [Line Items]
Convertible Debentures [Line Items]
Convertible debentures.
Percentage of interest in investment
Percentage Of Interest In Investment
Percentage of interest in investment.
Classes of share capital [domain]
Tranche.
Tranche [domain]
Disclosure of initial application of standards or interpretations [text block]
ADOPTION OF NEW ACCOUNTING STANDARDS
Disclosure of detailed information about intangible assets [line items]
Disclosure of terms and conditions of share-based payment arrangement [abstract]
Share-based payments
Share-based payments
Expense from share-based payment transactions with employees
Income before other income (expenses) and income taxes
Income before other income (expenses) and income taxes.
Income before other income (expenses) and income taxes
Netherlands
NETHERLANDS
Conversion of convertible debentures converted to common shares.
Conversion of Convertible Debentures Converted to Common Shares
Conversion of convertible debentures converted to common shares
United States of America
UNITED STATES
Classes of share capital [axis]
Classes of share capital [axis]
Share capital
Description of accounting policy for issued capital [text block]
Shares issued pursuant to issuance of common shares
Share issue related cost
Work in process
Current work in progress
Percentage of contingent earnout payment based on EBITDA
Percentage Of Contingent Earnout Payment Based On EBITDA
Percentage of contingent earnout payment based on EBITDA.
BioClue B.V [Member]
BioClue B.V.
BioClue BV
Computer Software
Computer software [member]
Weighted Average Exercise Price Warrants Expired
Weighted average exercise price warrants expired
Expired, Weighted average exercise price
Option Eleven [Member]
Option eleven.
Option Expiry Date November 13, 2033
Total post-employment benefit expense in profit or loss
Severance
Post-employment benefit expense in profit or loss
Cash Flows
Increase (decrease) through financing cash flows, liabilities arising from financing activities
Market price
Weighted average share price
Weighted average share price
Shares issued pursuant to option exercise, shares
Increase Decrease Through Exercise Of Options Number Of Shares
Increase (decrease) through exercise of options, number of shares.
Director compensation (included in salaries)
Key Management Personnel Compensation Director Compensation Included In Salaries
Key management personnel compensation Director compensation included in salaries.
SUBSEQUENT EVENTS
Disclosure of events after reporting period [text block]
Number of options, Exercisable
Number of share options exercisable in share-based payment arrangement
Talem Therapeutics LLC ("Talem")
Talem Therapeutics L L C Talem [Member]
Talem Therapeutics LLC ("Talem").
Critical Accounting Estimates And Judgments [Abstract]
Critical accounting estimates and judgments.
Disclosure of geographical areas [abstract]
Options outstanding
Number of options, Outstanding, Beginning balance
Number of options, Outstanding
Number of share options outstanding in share-based payment arrangement
Entity Address, City or Town
Later than three years and not later than four years [member]
2030
Total non-current assets
Non-current assets
Europe
Europe [Member]
Disclosure Of Nature Of Operations [Text Block]
Disclosure of nature of operations.
NATURE OF OPERATIONS
Amounts receivable
Adjustments for decrease (increase) in trade accounts receivable
Exercise price $
Warrants Outstanding Exercise Price
Warrants outstanding exercise price.
MindWalk B.V. [Member]
MindWalk B.V.
MindWalk B.V.
MindWalk
Disclosure Of Classes Of Share Capital [Line Items]
Disclosure of classes of share capital [line items]
Shares issued pursuant to warrant exercise, shares
Increase Decrease Through Exercise Of Warrants Number Of Shares
Increase (decrease) through exercise of warrants, number of shares.
Deferred income tax liability
Deferred tax liabilities
Deferred acquisition payments
Current Deferred Acquisition Payments
Current deferred acquisition payments.
Statement of changes in equity [abstract]
Net income (loss)
Net loss for the period
Profit (loss)
Operating losses
NET LOSS FOR THE PERIOD
Cash on hand
Cash on hand
Document Period End Date
SEGMENTED INFORMATION AND ECONOMIC DEPENDENCE
Disclosure of entity's operating segments [text block]
Disclosure of non-current assets or disposal groups classified as held for sale [text block]
Summary of Divestiture Classified as Held for Sale
Categories of related parties [axis]
Categories of related parties [axis]
Option Two [Member]
Option two.
Option Expiry Date January 13, 2027
Warrants outstanding
Balance, Number of warrants
Balance, Number of warrants
Number Of Warrants Outstanding
Number of warrants outstanding.
Disclosure of non-adjusting events after reporting period [table]
Stock options granted
Number of instruments granted in share-based payment arrangement
Beginning balance
Ending balance
Right-of-use assets
Awarded to
Share Based Payment Grantee Description
Share based payment grantee description.
Number of right of use assets leased
Number Of Right Of Use Assets Leased
Number of right of use assets leased.
Leases
Noncurrent Leases
Noncurrent leases.
Total issued capital
Share capital
Issued capital
Option Nine [Member]
Option Nine.
Option 9
Option Expiry Date June 11, 2033
Tax income (expense)
Income taxes
Income taxes (recovery)
Tax expense (income)
Income Taxes
ImmunoPrecise Antibodies (USA) Ltd. ("IPA USA")
Immuno Precise Antibodies U S A Ltd I P A U S A [Member]
ImmunoPrecise Antibodies (USA) Ltd. ("IPA USA").
Total expenses
Expenses, by nature
ImmunoPrecise Antibodies (N.D.) Ltd.
Immuno Precise Antibodies N D Ltd [Member]
ImmunoPrecise Antibodies (N.D.) Ltd.
Proceeds from sale of common shares
Proceeds from Sale of Common Shares
Proceeds from sale of common shares.
Amortisation, intangible assets other than goodwill
Amortization of intangible assets
Amortization on the intangible assets
Amortisation, intangible assets other than goodwill
Unvested
Number Of Unvested Share Options
Number of unvested share options.
Products and services [domain]
Dividend yield
Expected dividend as percentage, share options granted
Ranges of exercise prices for outstanding share options [domain]
Accounts payable and accrued liabilities
Adjustments for increase (decrease) in trade and other payables
Share price on grant date
Weighted average share price, share options granted
Profit (loss) from continuing operations
NET LOSS FROM CONTINUING OPERATIONS
Share-based payments, shares
Increase Decrease Through Sharebased Payment Transactions Number Of Shares
Increase decrease through sharebased payment transactions number of shares.
January 1, 2024
One January Twenty Twenty Four Member
One January twenty twenty four.
Entity File Number
Remaining life (year)
Remaining Life Of Outstanding Share Options
Remaining life of outstanding share options.
Deposit on equipment
Deposit On Equipment
Deposit on equipment.
Cover [Abstract]
YA II PN, Ltd [Member]
YA II PN, Ltd.
YA II PN, Ltd.
Disclosure of quantitative information about right-of-use assets [line items]
Supplies and parts
Current production supplies
Tranche One [Member]
Tranche One
Tranche One
RELATED PARTY TRANSACTIONS
Disclosure of related party [text block]
Current liabilities
Current liabilities [abstract]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Deferred revenue
Current Deferred Revenue
Current deferred revenue.
Description of vesting requirements for share-based payment arrangement
Vesting period
Description of vesting requirements for share-based payment arrangement
Current tax assets, current
Taxes receivable
Schedule of In Tabular Form Of Allocating Goodwill To Cash Generating Units
Disclosure In Tabular Form Of Allocating Goodwill To Cash Generating Units [Table Text Block]
Disclosure In Tabular Form Of Allocating Goodwill To Cash Generating Units
Summary of Changes in Stock Option
Disclosure of number and weighted average exercise prices of share options [text block]
Total income taxes paid (refund)
Cash paid for income tax
Income taxes paid (refund)
Range of remaining term
Remaining Lease Term
Remaining lease term.
Computer Hardware
Computer Hardware [Member]
Computer Hardware.
Beginning balance, shares
Ending balance, shares
Number of shares outstanding
Inventory
Adjustments for decrease (increase) in inventories
Disclosure of terms and conditions of share-based payment arrangement [line items]
Capital requirements [domain]
Later Than One Year and Not Later Than Two Years
Later than one year and not later than two years [member]
2028
Cash paid for interest
Cash Paid For Interest
Cash paid for interest.
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
Increase (decrease) in cash during the period
Risk- free rate
Risk free interest rate
Risk free interest rate, share options granted
Financial instruments
Description of accounting policy for financial instruments [text block]
Profit or loss [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Option Three [Member]
Option Three.
Option Expiry Date May 15, 2027
Statement of financial position [abstract]
Gross profit
GROSS PROFIT
Gross profit
Option Five [Member]
Option five.
Option Expiry Date February 19, 2028
Types of investment property [domain]
January 23, 2023
Twenty Three January Twenty Twenty Three [Member]
Twenty Three January Twenty Twenty Three.
Vested
Number Of Vested Share Options
Number of vested share options.
Disclosure Of Investment [Abstract]
Disclosure of investment.
Summary of Expenses Recognized for Employee Benefits
Disclosure of detailed information about employee benefits [explanatory]
Disclosure of detailed information about employee benefits.
Current assets
Current assets [abstract]
Disclosure of effects of adjustment on financial statements.
Disclosure Of effects of adjustment on financial statements
Summary of Effects of Adjustment on Financial Statements
Classes of assets [domain]
Weighted average exercise price, Granted
Weighted average exercise price of share options granted in share-based payment arrangement
Convertible Debentures [Abstract]
Convertible debentures.
Components of equity [axis]
Components of equity [axis]
Types of antidilutive instruments [axis]
Items not affecting cash
Cash flows from (used in) operations before changes in working capital
March 15, 2023
Fifteen March Twenty Twenty Three [Member]
Fifteen March Twenty Twenty Three.
Accumulated Depreciation
Accumulated Depreciation Amount [Member]
Accumulated depreciation amount [Member].
BioClue BV [Member]
Bioclue BV.
BioClue BV
Business combinations [domain]
Increase Decrease Through Restricted Stock Unit Number of Shares
Increase decrease through restricted stock unit number of shares.
Shares issued pursuant to RSU vesting, shares
CONVERTIBLE DEBENTURES
Convertible Debentures Explanatory [Text Block]
Convertible debentures.
Leases
Lease liabilities [member]
Amortization and depreciation
Adjustments for depreciation and amortisation expense
Equipment and leasehold improvements
Description of accounting policy for property, plant and equipment [text block]
Business combinations [axis]
Business combinations [axis]
Basis Of Accounting [Abstract]
Basis of accounting.
Disclosure of analysis of single amount of discontinued operations [text block]
Summary of Discontinued Operations
Basic earnings (loss) per share from continuing operations
LOSS PER SHARE FROM CONTINUING OPERATIONS- BASIC
Unbilled revenue
Adjustments For Decrease Increase In Unbilled Revenue
Adjustments for decrease (increase) in unbilled revenue.
Maturity [domain]
Beginning balance
Ending balance
Liabilities arising from financing activities
Inventories
Inventory
Current inventories
Allowance for credit losses
Allowance For Credit Losses
Allowance for credit losses.
Cash flows from (used in) financing activities, discontinued operations
Net cash flows from (used in) financing activities, discontinued operations
Net cash used in financing activities
Document Fiscal Year Focus
Common Shares
Potential ordinary share transactions [member]
Maturity [axis]
Maturity [axis]
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING
Weighted average number of ordinary shares used in calculating basic earnings per share
Geographical areas [domain]
Option Seven [Member]
Option seven.
Option Expiry Date January 4, 2033
Subsidiaries [axis]
Subsidiaries [axis]
Leases of low value assets
Expense relating to leases of low-value assets for which recognition exemption has been used
Cost
Gross carrying amount [member]
Canada
CANADA
North America
North America [Member]
Current tax liabilities, current
Income taxes payable
January 4, 2023
Four January Twenty Twenty Three [Member]
Four January Twenty Twenty Three.
CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS
Disclosure Of Critical Accounting Estimates And Judgments [Text Block]
Disclosure of critical accounting estimates and judgments.
Cash flows from (used in) operating activities, discontinued operations
Net cash flows from (used in) operating activities, discontinued operations
Net cash used in operating activities
Items that will be reclassified subsequently to loss
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Disclosure Of Significant Investments In Subsidiaries [Table]
Disclosure of subsidiaries [table]
Number of options, Forfeited
Number of share options forfeited in share-based payment arrangement
LIABILITIES
Liabilities [abstract]
Financing activities:
Cash flows from (used in) financing activities [abstract]
INTANGIBLE ASSETS
Disclosure of intangible assets [text block]
Income taxes
Description of accounting policy for income tax [text block]
Range [domain]
Weighted average exercise price, Unvested
Weighted Average Exercise Price Of Share Options Unvested In Share Based Payment Arrangement
Weighted average exercise price of share options unvested in share-based payment arrangement.
Volume-weighted average price
Volume-Weighted Average Price
Volume-weighted average price.
Statement Of Changes In Equity [Line Items]
Statement of changes in equity [line items]
Loss before other income (expenses) and income taxes
Loss Before Other Income Expenses And Income Taxes
Loss before other income (expenses) and income taxes.
Loss before other income (expenses) and income taxes
Total property, plant and equipment
Property and equipment
Beginning balance
Ending balance
Property, plant and equipment
Number of options, Granted
Stock options granted
Number of share options granted in share-based payment arrangement
Revenue from customers accounted for more than 10% of revenue
Revenue from Customers Accounted for More Than 10 Percentage of Revenue
Revenue from customers accounted for more than 10 percentage of revenue.
Summary of Classification and Measurement of Financial Assets and Liabilities
Disclosure Of Financial Assets And Liabilities At Date Of Initial Application Of IFRS 9 Explanatory [Text Block]
Disclosure of financial assets and liabilities at date of initial application of IFRS 9 explanatory.
OTHER INCOME (EXPENSES)
Other Income Expenses [Abstract]
Other income (expenses).
Types of investment property [axis]
Conversion of convertible debentures.
Conversion of Convertible Debentures
Conversion of convertible debentures
March 1, 2023
First March Twenty Twenty Three [Member]
First March Twenty Twenty Three.
No. of leases with options to purchase
Number Of Leases With Variable Payments Linked To Index
Number of leases with variable payments linked to index.
Disclosure of detailed information about property, plant and equipment [abstract]
Later than two years and not later than three years [member]
2029
Summary of Detailed Information About Inventories
DisclosureOfDetailedInformationAboutInventoriesExplanatory [Text Block]
Disclosure of detailed information about inventories explanatory.
Furniture and Equipment
Fixtures and fittings [member]
Tranche [Axis]
Tranche
Disclosure of detailed information about financial instruments [abstract]
Summary of Changes in Liabilities Arose From Financing Activities
Disclosure of reconciliation of liabilities arising from financing activities [text block]
Disclosure of basis of preparation of financial statements [text block]
BASIS OF PRESENTATION AND MATERIAL ACCOUNTING POLICIES
February 1, 2024
One February Twenty Twenty Four Member
One February twenty twenty four.
Number of option, Expired
Number of share options expired in share-based payment arrangement
Shares issued pursuant to issuance of common shares, Shares
Shares In Issuance Of Common Shares
Shares in issuance of common shares.
Summary of Revenues Allocated According to Revenue Types
Disclosure of products and services [text block]
Directors
Director [Member]
Measurement of the lease liability
Expenses Relating To Payment Not Included In The Measurement Of Lease Liability
Expenses relating to payment not included in the measurement of lease liability.
Building
Buildings [member]
Depreciation
Depreciation, right-of-use assets
Lab and office facilities
Lab And Office Facilities [Member]
Lab and office facilities.
May 23, 2023
Twenty Three May Twenty Twenty Three Member
Twenty three May twenty twenty three.
Disclosure Of Classes Of Share Capital [Table]
Disclosure of classes of share capital [table]
Weighted average life remaining (years), Exercisable
Weighted average exercise price of share options exercisable in share based payment arrangements
Weighted average exercise price of share options exercisable in share based payment arrangements.
Accumulated Depreciation
Accumulated depreciation and amortisation [member]
Option Four And Five [Member]
Option Four And Five.
Option 4 and 5
Restricted Stock Units
Restricted share units [member]
Product Sales Revenue
Product Sales [Member]
Product sales.
SHAREHOLDERS' EQUITY
Equity [abstract]
Borrowings by name [axis]
Borrowings by name [axis]
Classes of intangible assets other than goodwill [axis]
Classes of intangible assets other than goodwill [axis]
Proceeds on share issuance, net of transaction costs
Proceeds from (payments for) issuing shares
Proceeds from (payments for) issuing shares.
Disclosure Of Intangible Assets [Table]
Disclosure of detailed information about intangible assets [table]
COMMITMENTS
Disclosure of commitments [text block]
Total assets
Assets at beginning of period
Assets at end of period
Assets
Number of options, Unvested
Number Of Share Options Unvested In Share Based Payment Arrangement
Number of share options unvested in share-based payment arrangement
Foreign exchange
Adjustments for unrealised foreign exchange losses (gains)
Cash is comprised of:
Cash and cash equivalents [abstract]
Salaries and other short-term benefits
Key Management Personnel Compensation Salaries And Other Short Term Benefits
Key management personnel compensation salaries and other short-term benefits.
Discontinued operations intangible assets other than goodwill
Discontinued operations intangible assets other than goodwill.
Discontinued operations
Discontinued operations
Schedule of Schedule of Compensation For Key Management
Disclosure of transactions between related parties [text block]
Contributed surplus
Contributed Surplus
Contributed surplus.
Employees
Employees [Member]
Employees.
Components of equity [domain]
Shares issued pursuant to deferred payment for acquisition
Shares issued pursuant to deferred acquisition
Increase (decrease) through acquisition of subsidiary, equity
Balance, Weighted average exercise price
Balance, Weighted average exercise price
Weighted Average Exercise Price Warrants Outstanding
Weighted average exercise price warrants outstanding.
FINANCIAL INSTRUMENTS
Disclosure of financial instruments [text block]
Other income (expenses)
Other operating income (expense)
Weighted average exercise price outstanding, Beginning balance
Weighted average exercise price outstanding, Ending balance
Weighted average exercise price of share options outstanding in share-based payment arrangement
August 8, 2023
Eight August Twenty Twenty Three Member
Eight August twenty twenty three.
Unbilled revenue
Current Unbilled Revenue
Current unbilled revenue.
Disclosure of quantitative information about right-of-use assets [table]
Range two.
Range two [Member]
Range Two
Weighted Average Exercise Price Of Share Options Issued In Share Based Payment Arrangement
Weighted Average Exercise Price Of Share Options Issued In Share Based Payment Arrangement
Weighted average exercise price, Issued
Depreciation
Acquisitions through business combinations, property, plant and equipment
Interest, accretion and other income
Interest, accretion and other income
Allowances For Doubtful Accounts [Abstract]
Allowances For Doubtful Accounts.
Deferred Acquisition Payments
Deferred Acquisition Payments [Member]
Deferred acquisition payments.
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table]
Disclosure of reconciliation of liabilities arising from financing activities [table]
Total adjustments for increase (decrease) in deferred income including contract liabilities
Deferred revenue
Adjustments for increase (decrease) in deferred income including contract liabilities
Weighted average exercise price, Expired
Weighted average exercise price of share options expired in share-based payment arrangement
BioStrand
Biostrand
BioStrand [Member]
BioStrand
Entity Registrant Name
Three August Twenty Twenty Four [Member]
Three august twenty twenty four.
August 3, 2024
Aggregate continuing and discontinued operations [member]
Conversion price
Convertible debentures conversion price
Convertible Debentures Conversion Price
Convertible debentures conversion price
Schedule of Contractual Cash Flow Requirements
Disclosure of financial liabilities [text block]
Statement Of Changes In Equity [Table]
Statement of changes in equity [table]
Net Book Value
Net Book Value [Member]
Net Book Value
Convertible Debentures [Table]
Convertible Debentures [Table]
Convertible debentures.
No. of leases with extension options
Number Of Leases With Extension Options
Number of leases with extension options.
Disclosure Of Significant Accounting Policies [Abstract]
Disclosure of significant accounting policies.
Officers and employees.
Officers And Employees [Member]
Officers and employee
Issued, Weighted average exercise price
Weighted Average Exercise Price Warrants Issued
Weighted average exercise price warrants issued.
Name of Subsidiary
Name of subsidiary
Equity
Shareholders Equity
Beginning balance
Ending balance
Equity
Total shareholders' equity
Cash flows from continuing and discontinued operations [abstract]
Cash from discontinued operations:
Classes of property, plant and equipment [domain]
Schedule of Future Minimum Lease Payments Related to Equipment under Finance Lease and Office Lease Obligation
Disclosure Of Detailed Information About Maturity Analysis Of Finance Lease And Office Lease Explanatory
Disclosure of detailed information about maturity analysis of finance lease and office lease.
Number of Share Options Vested and Outstanding
Number of share options vested and outstanding.
GRANT AND SUBSIDY INCOME
Disclosure of government grants [text block]
Proprietary processes
Proprietary Processes
Proprietary Processes [Member]
Proprietary processes.
Option Seven To Twelve [Member]
Option seven to twelve.
Option 7 to 12
Option Four [Member]
Option four.
Option Expiry Date February 19, 2027
Grant And Subsidy Income [Abstract]
Grant and subsidy income.
General and administrative
Office and general
General and administrative expense
Accumulated deficit
Total retained earnings
Accumulated deficit
Retained earnings
Intangible assets material to entity [axis]
Intangible assets material to entity [axis]
Summary of Stock Option Awards
Disclosure of terms and conditions of share-based payment arrangement [text block]
IPA Europe B V
IPA Europe B V [member]
IPA Europe B V.
Disclosure Of Property Plant And Equipment [Table]
Disclosure of detailed information about property, plant and equipment [table]
Convertible Debentures
Convertible Debentures [Member]
Convertible debentures.
Changes In Non Cash Working Capital Related To Operations
Changes in non-cash working capital related to operations.
Changes in non-cash working capital related to operations:
Intellectual property
Intellectual Properties
Intellectual Properties [Member]
Intellectual properties.
Impairment loss
Impairment Loss Of Divestiture Classified As Held For Sale
Impairment loss of divestiture classified as held for sale.
Sales and marketing
Sales and marketing expense
Tranche Two [Member]
Tranche Two
Tranche Two
Schedule of information for cash-generating units
Disclosure of information for cash-generating units [text block]
Weighted average
Weighted average [member]
Grant date
Date of grant of share-based payment arrangement
Purchase of property, plant and equipment
Purchase of property, plant and equipment, classified as investing activities
Purchase of property and equipment
Research and development
Research and development expense
Disclosure of analysis of single amount of discontinued operations [abstract]
Schedule of Lease Payments Not Recognized Liability
Disclosure Of Lease Payments Not Recognized As Liability
Disclosure of lease payments not recognized as liability.
Statement of cash flows [abstract]
Functional Currency
Description of functional currency
Amounts receivable, net
Amounts Receivable Net
Amounts Receivable Net.
Restricted cash
Restricted cash and cash equivalents
INVENTORIES
Disclosure of inventories [text block]
Disclosure Of Income Taxes [Abstract]
Disclosure of income taxes.
Key management personnel compensation, share-based payment
Share-based payments
Classes of assets [axis]
Classes of assets [axis]
ImmunoPrecise Antibodies (Europe) B.V. ("IPA Europe")
Immuno Precise Antibodies Europe B V I P A Europe Formerly Modi Quest Research B V [Member]
ImmunoPrecise Antibodies (Europe) B.V. ("IPA Europe", formerly ModiQuest Research B.V.
Non-adjusting events after reporting period [domain]
Operating activities:
Cash flows from (used in) operating activities [abstract]
Leases
Current Leases
Current leases.
Expected volatility
Expected volatility, share options granted
Entity Address, Country
Inventory
Description of accounting policy for measuring inventories [text block]
Leasehold Improvements
Leasehold improvements [member]
Summary of Amortization for intangible assets with finite lives is provided over the following terms
Disclosure of detailed information about intangible assets [text block]
Antibodies
Antibodies
Antibodies
Schedule of Estimated Term of Asset
Disclosure Of Estimated Term Of Asset Explanatory [Text Block]
Disclosure of estimated term of asset explanatory.
Common stock aggregate gross sales price
Common stock aggregate gross sales price
Common stock aggregate gross sales price
Finder's Warrants
Finders Warrants [Member]
Finders warrants.
Conversion to shares
Issue of convertible debentures
Shares issued pursuant to conversion of convertible debentures
Issue of convertible instruments
February 19, 2024
Nineteen February Twenty Twenty Four Member
Nineteen February twenty twenty four.
Number of share options issued in share based payment arrangement
Number of share options issued in share based payment arrangement.
Number of options, Issued
Automobile
Vehicles [member]
Warrant exercisable price
Class Of Warrant Exercisable Price
Class of warrant exercisable price.
Grant income
Income from government grants
Deferred tax assets
Deferred tax assets
Deferred tax asset
Disclosure Of Significant Investments In Subsidiaries [Line Items]
Disclosure of subsidiaries [line items]
Weighted average life remaining, Issued (years)
Weighted Average Life Remaining Issued Class Of Warrants
Weighted average life remaining issued class of warrants.
Cash and Cash Equivalents
Description of accounting policy for restricted cash and cash equivalents [text block]
April 2, 2023
Second April Twenty Twenty Three [Member]
Second April Twenty Twenty Three.
Management fees
Key Management Personnel Compensation Management Fees
Key management personnel compensation management fees.
Schedule of Changes in the Value of Right-of-Use Assets
Schedule of changes in the Value of the Right-of-Use Assets
Disclosure of quantitative information about right-of-use assets [text block]
Disposals
Disposals, property, plant and equipment
Total for all business combinations [member]
Presentation of leases for lessee [abstract]
Disclosure of nature of operations.
Disclosure of Nature of Operations [Abstract]
Disclosure of classes of share capital [abstract]
Share Capital
Issued capital [member]
Government grant
Description of accounting policy for government grants [text block]
Later than four years and not later than five years [member]
2031
Weighted average life remaining (years)
Weighted average remaining contractual life of outstanding share options
Exercised, Weighted average exercise price
Weighted Average Exercise Price Warrants Exercised
Weighted average exercise price warrants exercised.
Accumulated Other Comprehensive Income Loss
Accumulated other comprehensive income (loss).
Accumulated other comprehensive loss
Accumulated other comprehensive income
Idea Family B V [Member]
Idea Family B V.
Idea Family BV
Intangible assets
Description of accounting policy for intangible assets other than goodwill [text block]
Number Of Warrants Expired
Number of warrants expired
Expired, Number of warrants
Disclosure of changes in restricted stock units explanatory [text block]
Disclosure of changes in restricted stock units explanatory.
Summarizes Activity Related to RSUs
Employee benefits expense
Total employee benefits expense
Employee benefits expense
ImmunoPrecise Antibodies (MA) LLC
Immuno Precise Antibodies M A L L C [Member]
ImmunoPrecise Antibodies (MA) LLC.
Outstanding principal balance of of convertible debenture decrease amount.
Outstanding Principal balance of of Convertible debenture Decrease Amount
Outstanding principal balance of of convertible debenture decrease amount
Items not affecting cash:
Adjustments to reconcile profit (loss) [abstract]
Total current assets
Current assets
Liabilities arising from financing activities [axis]
Liabilities arising from financing activities [axis]
Option Six [Member]
Option six.
Option 6
Option Expiry Date January 19, 2029
Increase Decrease Through Assets Held For Sale Liabilities Arising From Financing Activities
Increase decrease through assets held for sale liabilities arising from financing activities.
Non-cash changes, Assets held for sale
Expiry Date
Warrants Outstanding Expiry Date
Warrants outstanding expiry date.